Cost-utility of IDegLira versus alternative basal insulin intensification therapies in patients with type 2 diabetes mellitus uncontrolled on basal insulin in a Chinese setting by Junling Weng, Dunming Xiao, Yingyao Chen

Get full text

The cost-effectiveness analysis of newborn screening for inherited metabolic disorders in China using tandem mass spectrometry: a real-world evidence by Dunming Xiao, Jiaqi Yuan, Shimeng Liu, Yi Yang, Yingyao Chen

Get full text

Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbu... by Dunming Xiao, Junling Weng, Lei Zhang, Chang Xing, Yan Wei, Yingyao Chen

Get full text

Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand by Dai Lian, Yue Suo, Ruoyan Gai, Ning li, Yunfeng Ren, Dunming Xiao, Jiaxin Zhao, Mingdong Zhang, Shimeng Liu, Yingyao Chen

Get full text